About us
Medical Advisory Board
Our medical advisory board
Team
Get to know the people behind Cannovum
News
Latest news about Cannovum
Career
Become part of the European cannabis revolution
Home
Investor Relations
Anbau-Allianz
Health
Home
Investor Relations
Health
Here you can trade our stock
Cannovum Cannabis AG
TICKER: 27N.DE (Xetra)
WKN: A2LQU2
ISIN: DE000A2LQU21
Profit from the cannabis revolution.
Legalization is just around the corner. Profit from the boom - with stock of
Cannovum Cannabis AG
.
Trading platforms
TICKER: 27N.DE (Xetra)
WKN: A2LQU2
ISIN: DE000A2LQU21
TICKER: 27N.DE (Xetra)
WKN: A2LQU2
ISIN: DE000A2LQU21
Facts and figures
+ 1,200 %
Sales growth
compared to the year 2021
10 %
Regular customers
of all pharmacies distributing cannabis
> €8 billion
Market potential for legal cannabis per year
Our stock
Stock exchanges
Düsseldorf, Frankfurt, Xetra, Tradegate, Munich, Hamburg, Berlin, gettex
Share capital
2.536.200 €
Number of shares
2,536,200 pcs.
CURRENT SHARE PRICE
X€
Last updated: waiting
27N stock chart
from TradingView
TICKER: 27N.DE (Xetra)
WKN: A2LQU2
ISIN: DE000A2LQU21
TICKER: 27N.DE (Xetra)
WKN: A2LQU2
ISIN: DE000A2LQU21
Trading platforms
Downloads
Analysis and company information
ANALYST
Sphene Capital
Recommendation
Buy
Target price
11,40 €
Research
April 2023
PDF
April 2023
Stock analysis
PDF
April 2023
Data sheet
Financial reports and corporate calendar
Financial reports
Company calendar
2022
2021
2020
2019
Half-year financial statements Cannovum Health eG 2022
Half-year financial statements Cannovum AG 2022
Annual financial statements Cannovum Health eG 2021
Half-year financial statements Cannovum AG 2021
Annual financial statements Cannovum AG 2021
Annual financial statements Cannovum AG 2020
Cannovum AG 2020 half-year financial statements
Annual financial statements Cannovum AG 2019
2023
Publication of half-year financial statements as of June 30, 2023
SEP
Annual General Meeting
JUL
Publication of annual financial statements as of Dec. 31, 2022
JUN
Newsroom
Media
Press releases
IR messages
Current articles
12 Apr 2023
WDR Aktuelle Stunde Interview with CEO Pia Marten
The latest developments on cannabis legalization - a short interview with Cannovum AG CEO Pia Marten.
Read more
WDR
01 Apr 2023
How organic grass can compete with black market prices
So far, start-up Cannovum has been selling medical cannabis. With the legalization, however, they also want to enter the pleasure market...
Read more
Watson
March 31, 2023
Karl Lauterbach plans cannabis legalization light
The Minister of Health wants to legalize weed in model regions in the future. A flagship project of the traffic light would thus remain strongly behind the ...
Read more
The time
Past articles
2 Feb 2023
Rhenish Post
31 Jan 2023
Focus Money
31 Jan 2023
WirtschaftsWoche
20 Dec 2022
Akitenlust
30 Nov 2022
FAZ
19 Nov 2022
Focus Money
02 March 2022
FAZ
05 Jan 2021
Handelsblatt
04 June 2021
wallstreet:online
07 Oct 2021
Business punk
06 Feb 20023
Cannovum Cannabis AG: Annual financial statements 2022 and issuance of further convertible bonds
Read more
May 12, 2023
Cannovum Cannabis AG Signs Agreement Together With Co-Founders to Establish Germany’s First Cultivation Alliance For Cannabis Anbau-Allianz für Deutschland GmbH
Read more
25 Apr 2023
Focus on pleasure cannabis and change of name to Cannovum Cannabis AG
Read more
Apr. 19, 2023
Cannovum AG develops cultivation kits for cannabis clubs
Read more
17 Apr 2023
Cannovum AG: Co-founder Marius Koose withdraws from the operational business
Read more
02 Feb 2023
Cannovum AG establishes the "Anbau-Allianz" for recreational cannabis in Germany
Read more
15 Dec 2022
Cannovum AG share enters Xetra trading
Read more
07 Dec 2022
Cannovum AG enters into medical cannabis supply agreement with WEECO
Read more
28 Nov 2022
Cannovum AG share moves to primary market of Düsseldorf Stock Exchange as of 1.12.2022
Read more
25 Nov 2022
Cannovum AG expands management board
Read more
19 Oct 2022
Cannovum AG welcomes concrete steps towards the legalization of cannabis as a stimulant
Read more
10 Oct 2022
Joint research project with Macromedia University on the future of investor communication
Read more
07 Sept 2022
Cannovum AG record sales and new customers in the first half of 2022
Read more
04 Jul 2022
Cannovum AG part of the International Expert Hearings on Cannabis Legalization
Read more
27 Apr 2022
Cannovum AG resolves capital increase from authorized capital excluding subscription rights
Read more
09 Feb 2022
Cannovum AG launches Cannabis Medical Education Platform
Read more
06 Jan 2022
Cannovum AG now with Next Day Delivery for medical cannabis
Read more
25 Nov 2021
Cannovum AG decides to enter the over-the-counter cannabis market
Read more
28 Sept 2021
Cannovum AG receives active ingredient license
Read more
08 Sept 2021
Cannovum AG expands Supervisory Board and Medical Advisory Board
Read more
06 Sept 2021
Cannovum AG launches European cannabis expansion
Read more
29 Jun 2021
Cannovum AG enters the cannabis whole extract market with its own brand
Read more
24 Jun 2021
Cannovum AG enters into medical cannabis supply agreement with Aurora Europe
Read more
15 Jun 2021
Cannovum AG opens up further cannabis market segment with dronabinol
Read more
May 6, 2021
Cannovum AG starts with direct listing on the Düsseldorf Stock Exchange
Read more